letrozole has been researched along with 4-hydroxy-n-desmethyltamoxifen in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cushman, M; Flockhart, DA; Ipe, J; Jin, HS; Liu, J; Lv, W; Skaar, TC; Zhao, LM | 1 |
| Berti, F; Colombo, G; Grazioso, G; Magistrato, A; Martini, S; Pavlin, M; Pennati, M; Sgrignani, J; Spinello, A; Zaffaroni, N | 1 |
| Belluti, F; Bisi, A; Caciolla, J; Fimognari, C; Gobbi, S; Magistrato, A; Martini, S; Pavlin, M; Rampa, A; Simonelli, F; Spinello, A; Turrini, E; Zaffaroni, N | 1 |
| Fitton, JH; Lowenthal, RM; McGuinness, G; Olesen, I; Oliver, LJ; Patel, R; Peterson, GM; Shastri, M; Tocaciu, S | 1 |
| Ames, MM; Bruinsma, ES; Buhrow, SA; Carter, JM; Cheng, J; Goetz, MP; Hawse, JR; Hoskin, TL; Hou, X; Ingle, JN; Jayaraman, S; Kalari, KR; Kuffel, MJ; McGovern, RM; Monroe, DG; Reid, JM; Reinicke, KE; Safgren, SL; Suman, VJ; Tang, X; Walden, CA; Zeldenrust, MA | 1 |
5 other study(ies) available for letrozole and 4-hydroxy-n-desmethyltamoxifen
| Article | Year |
|---|---|
A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.
Topics: Aromatase; Aromatase Inhibitors; Binding Sites; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; MCF-7 Cells; Molecular Structure; Protein Binding; Stilbenes; Structure-Activity Relationship | 2016 |
Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.
Topics: Allosteric Regulation; Antineoplastic Agents; Aromatase; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2019 |
Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Female; Humans | 2021 |
The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Herb-Drug Interactions; Humans; Letrozole; Middle Aged; Nitriles; Phytotherapy; Polysaccharides; Tamoxifen; Triazoles; Undaria | 2018 |
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer.
Topics: Animals; Apoptosis; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; Letrozole; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Receptors, Estrogen; Tamoxifen; Xenograft Model Antitumor Assays | 2020 |